Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
Status:
Withdrawn
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The investigators will determine the prevalence of gastroesophageal reflux disease (GERD) in
Eosinophilic Esophagitis (EoE) and importantly determine the predictors of response to Proton
Pump Inhibitor (PPI) therapy in EoE. Moreover, the investigators will determine the effect of
GERD on the location of esophageal eosinophilia.